The DDI Study of SP2086 and Simvastatin

NCT02817243 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: SP2086
DRUG: Simvastatin

Sponsor

Jiangsu HengRui Medicine Co., Ltd.